Hoechst Pakistan Limited (PSX:HPL)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
4,016.48
+16.48 (0.41%)
At close: Apr 27, 2026
33.71%
Market Cap 38.74B
Revenue (ttm) 31.08B
Net Income (ttm) 3.06B
Shares Out 9.64M
EPS (ttm) 317.04
PE Ratio 12.67
Forward PE n/a
Dividend 240.00 (5.98%)
Ex-Dividend Date Apr 1, 2026
Volume 243
Average Volume 588
Open 4,050.00
Previous Close 4,000.00
Day's Range 3,927.00 - 4,050.00
52-Week Range 2,901.01 - 4,889.99
Beta 0.34
RSI 50.40
Earnings Date Apr 22, 2026

About Hoechst Pakistan

Hoechst Pakistan Limited, together with its subsidiary, manufactures, sells, and trades in pharmaceutical and related products in Pakistan, Afghanistan, and internationally. The company offers allergy management, anti-diarrheals, antibiotics, antiemetic, cardiology, consumer healthcare, diabetes, neurology, and emergency care products under various brand names, as well as vaccines. It exports its products. The company was formerly known as Sanofi-Aventis Pakistan Limited and changed its name to Hoechst Pakistan Limited in September 2023. Hoechs... [Read more]

Industry Pharmaceutical Preparations
Founded 1967
Employees 957
Stock Exchange Pakistan Stock Exchange
Ticker Symbol HPL
Full Company Profile

Financial Performance

In 2025, Hoechst Pakistan's revenue was 30.96 billion, an increase of 15.73% compared to the previous year's 26.75 billion. Earnings were 2.90 billion, an increase of 56.16%.

Financial Statements

News

There is no news available yet.